Immuron shares jump after exclusive U.S. distribution deal
Immuron (IMRN) shares surged more than 60% after the biopharmaceutical company signed an exclusive agreement with Sweden’s Calmino Group to distribute digestive-health product Proibs in the U.S.
Shares of Immuron (IMRN) surged more than 60% on Friday after the biopharmaceutical company signed an exclusive agreement with Sweden’s Calmino Group to distribute digestive-health product Proibs in the U.S.IMRN stock hit its highest levels since November 2025 and is on track to clock its biggest s…